3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Depression
4
Head and Neck Neoplasms
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Fatigue
2
Anxiety Disorders
2
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Sleep Wake Disorders
1
Recurrence
1
Radiation Fibrosis Syndrome
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Patient Acceptance of Health Care
1
Pain
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Calculi
1
Inflammatory Breast Neoplasms
1
Immune Checkpoint Inhibitor-Induced Dermatitis
1
Health Education
1
Constriction, Pathologic
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
Cyclophosphamide
3
Tacrolimus
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Busulfan
2
fludarabine
1
Transplantation
1
Radiotherapy
1
Methotrexate
1
Health Promotion
1
Etoposide
1
Educational Status
1
Cyclosporine
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Aplastic
×
Therapeutics
×
90 days
×
Clear all
No trials found.